BAY2328065
Sponsors
Bayer
Conditions
Endometriosis
Phase 1
BAY2328065 Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Relative Bioavailability, Food Effect
CompletedNCT03427788
Start: 2018-03-21End: 2019-02-11Updated: 2024-02-29
A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants
CompletedNCT04851483
Start: 2021-04-28End: 2022-02-14Updated: 2022-06-01